KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement

Nature

Volumn 403, Issue 6767, 2000, Pages 325-328

  Huard, Bertrand ^a,b,c   Karlsson, Lars ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CELL SURFACE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

ANTI-BACTERIAL AGENTS; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; HLA-C ANTIGENS; HUMANS; INTERFERON TYPE II; LIGANDS; LYMPHOCYTE ACTIVATION; MACROLIDES; MONOPHENOL MONOOXYGENASE; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; SELF TOLERANCE;

EID: 0034688172     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35002105     Document Type: Article

References (26)

1. Phillips, J. H., Gumperz, J. E., Parham, P. & Lanier, L. L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268, 403-405 (1995).
2. Mingari, M. C. et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad. Sci. USA 93, 12433-12438 (1996).
3. Mingari, M. C. et al. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. Int. Immunol. 9, 485-491 (1997).
4. Lanier, L. L. NK cell receptors. Annu. Rev. Immunol. 16, 359-393 (1998).
5. Rajagopalan, S. & Long, E. O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189, 1093-1100 (1999).
6. Ponte, M. et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Prof. Natl Acad. Sci. USA 96, 5674-5679 (1999).
7. Lee, M. et al. HLA-E is a major ligand for the natural killer inhibitory receptor CP94/NKG2A. Proc. Natl Acad. Sci. USA 95, 5199-5204 (1998).
8. Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799 (1998).
9. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. & Brooks, A. G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-medialed lysis. J. Exp. Med. 187, 813-818 (1998).
10. Mingari, M. C., Moretta, A. & Moretta, L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol. Today 19, 153-157 (1998).
11. Moretta, A. et al. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14, 619-648 (1996).
12. Brichard, V. et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med. 178, 489-495 (1993).
13. Shimizu, Y. & DeMars, R. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142, 3320-3328 (1989).
14. Carena, I., Shamshiev, A., Donda, A., Colonna, M. & De Libero, G. Major histocompatibilily complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γδ stimulated by nonpeptidic ligands. J. Exp. Med. 186, 1769-1774 (1997).
15. Le Drean, E. et al. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A. Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28, 264-276 (1998).
16. Falk, C. S., Schendel, D. J. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. J. Exp. Med. 182, 1005-1018 (1995).
17. Valitutti, S., Muller, S., Salio, M. & Lanzavecchia, A. Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation. J. Exp. Med. 185, 1859-1964 (1997).
18. Fukuda, M., Viitala, J., Matteson, J. & Carlsson, S. R. Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Comparison of their deduced amino acid sequences. J. Biol. Chem. 263, 18920-18928 (1988).
19. van Deuers, B., Holan, P. K. & Sandvig, K. Inhibition of the vacuolar H(+)-ATPase with bafilomycin reduces delivery of internalized molecules from mature multivescular endosomes to lysosomes in HEp-2 cells. Eur. J. Cell Biol. 69, 343-350 (1996).
20. Valitutti, S., Muller, S., Cella, M., Padovan, E. & Lanzavecchia, A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375, 148-151 (1995).
21. Speiser, D. E. et al. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients, Eur. J. Immunol. 29, 1990-1999 (1999).
22. Höglund, P. et al. Host MHC class 1 gene control of NK-cell specificity in the mouse. Immunol. Rev. 155, 11-28 (1997).
23. Boullier, S. et al. Phosphoantigen activation induces surface translocation of intracellular CD94/ NKG2A class I receptor on CD94-peripheral Vσ9 VδT cells but not on CD94-thymic or mature gammadelta T cell clones. Eur. J. Immunol 28, 3399-3410 (1998).
24. Gumperz, J. E., Valiante, N. M., Parham, P., Lanier, L. L. & Tyan, D. Heterogenous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J. Exp. Med. 183, 1817-1827 (1996).
25. Cai, Z. et al. Transfected Drosophila cells as a probe for defining the minimal requirements for stimulating unprimed CD8+ T cells. Proc. Natl Acad. Sci. USA 93, 14736-14741 (1996).
26. Huard, B., Prigent, P., Tournier, M., Bruniquel, D. & Triebel, F. CD4/major histocompatibility complex class II interaction analyzed with CD4-and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins, Eur. J. Immunol. 25, 2718-2721 (1995).